views on our new md

I found yesterdays announcement disappointing for what it didnt talk about: news on the deployment of the vibracorer. It perhaps still hasnt been deployed? It perhaps is still having technical difficulties? The Bateman samples on which yesterdays news was about are perhaps from the work Dr Reid was in charge of? (not derived from the vibracorer, or our MD would have said so?). And everyday this MD draws $800 salary and everyday of delay in getting the scoping study completed is costing us utterly massively in dilution (or at least it will when the next fundraising takes place: we are forced to give away more of the company at a bottom-of the-cycle price to people like Minemakers). The $800 a day cash drain of our MD only increases our liquidity risk, which in turn impacts on the dilution risk. Mr Jordinson hasnt explained which shareholders approved him becoming MD. He hasnt explained satisfactorily why Dr Reid left the company, and the maiden quarterly report by Mr Jordinson was largely opinion and little fact, and amounted to a quarter of no or little progress (disguised with unsubstantiated opinion about the scoping study being well advanced, together with a shift in the goal posts being trumpeted as a "highlight").
I remain concerned that the portfolio of assets owned by the company will be fiddled with to suit the expertise (or lack of it) of our current MD. I would like to see our current MD leave UCL and move on to a penny dreadful explorer more suited to his skills (or lack of them?). His failure to buy any shares in our company is surprising and not surprising. And remember, he resigned from Copper Resources Corporation because he didnt want to relocate to South Africa (that companys share price went from over a 1 to around about a penny on the day it delisted and Mr Jordinson resigned about a year before CRC delisted: I dont have time to disentangle Copper Resources Corporations share price movements from events that were outside that companys control so I dont know if he was to blame for any or all of the loss in value there), but he sure didnt come to us trumpeting past value creation in previous director positions, did he? The sort of things that would impress me would be if he plugged himself into linguaphone Farsi, and passed a recognised qualification in it (a commitment to our Iranian asset?), moved himself offshore e.g. to the companys office in Dubai and if he bought about 25 million shares in our company as a sign of commitment (before we are diluted out of existence at the next fundraising). Anyone got any views on our new MD?

P.S. He still hasn't told us why our chairman resigned?